IDO1 and neoplasm: For example, the removal of Treg can reduce the tumor burden of mouse models 204, inhibit indoleamine 2,3-dioxygenase-1 activity and enhance the tumor-specific T cell response, reduce the conversion to Treg-like cells 205.